Tuberculosis is an infectious or sometimes fatal disease with mycobacteria its major cause. In common tuberculosis attacks the lungs, or even other parts of the body such as genitourinary system, lymphatic system and central nervous system. Tuberculosis caused in lungs is known as Pulmonary Tuberculosis while effects in other parts of the body is known as extra pulmonary Tuberculosis. It can be spread through air by cough, sneeze or transmit through air.
The major symptoms of tuberculosis are chronic cough, night sweat, blood-tinged sputum, and fever. According to the WTO report published on tuberculosis, 1.3 million died from the disease. The complexity of the treatment is increased by the detection of Multi Drug Resistant (MDR) as routine drug cannot be used for the treatment of the disease. Identification of tuberculosis at an early stage helps in effective treatment. Hence rapid identification tests are performed either in research laborites or in hospitals.
The various tests used in detection of tuberculosis are basically segmented into two methods namely rapid method and routine method. Routine method is the most prominent and widely used method for detection of tuberculosis which includes skin test. While rapid method of detection of tuberculosis includes polymerase chain reaction, cassette test, microscopic observation drug susceptibility, and enzyme linked immunosorbent spot test. Tuberculosis blood test measures hoe the immunity of the system reacts to bacteria of tuberculosis.
The basic customer for the tuberculosis testing market are basically people with HIV or another medical problem that weakens the immunity system, people from the country with common tuberculosis diseases such as Latin American countries, Africa, Asia, Russia, and Eastern Europe or people exposed to illegal drugs.
The geographical segment of the product is classified into four geographical regions around the world namely Asia-Pacific, European, North American, and Row. The market share of the Row market is expected to remain consistent, but growth prospects are severely high due to increasing number of tuberculosis cases in the market. North American market is expected to grow rapidly over the next few years because of increase in tuberculosis cases in homeless shelters, jails or some nursing homes. Europe and Asia-Pacific market have a large share of tuberculosis patients in the total world share out of which India and China alone have 5 million of tuberculosis patients according to the WTO report, hence the rapid increase in demand is expected over the next six years.
Increase in the number of infected cases all over the world, increasing awareness of health, prominent steps taken by various government of the various developing nations are key drivers of the tuberculosis testing market, whereas development of advanced and hybrid technique of multiple disorder detection is one the biggest restraints of the market.
Orasure technologies, Originate ventures, and Labcorp are market leaders of the tuberculosis testing market
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
"The quality of research they have done for us has been excellent."
The most common concern for the governments of all Covid-19 hit nations is the excruciating need to screen for and test large numbers of patients for possible Sars-Cov-2 infection. As a result, most of them are facing major shortages in the supply for diagnostic kits to test for the virus. Diagnostics virology entities are under immense pressure to provide reliable testing kits, and there is a surge in demand for in-vitro or point-of-care testing capacities by labs across a large number of countries. The report will account for Covid19 as a key market contributor.